AMBRY GENETICS CORPORATION

AMBRY GENETICS CORPORATION specializes in high-complexity genetic reference laboratory testing services, delivering advanced genomic analysis for clinical and research applications. Their core capabilities include next-generation sequencing, variant interpretation, and bioinformatics-driven diagnostics for inherited conditions, cancer predisposition, and rare diseases. The company operates a CAP-accredited, CLIA-certified laboratory infrastructure, ensuring regulatory compliance and analytical rigor in reporting actionable genetic findings. Key differentiators include proprietary assay panels, automated data pipelines, and expert curation of clinically significant variants, enabling precise, scalable testing for complex patient populations. The contractor maintains a consistent, long-standing relationship with the Department of Veterans Affairs, providing specialized genetic testing services to support veteran healthcare initiatives. Work performed under these engagements focuses on diagnostic confirmation, hereditary risk assessment, and personalized treatment guidance, aligning with VA’s mission to deliver precision medicine to enrolled beneficiaries. The recurring nature of awards suggests a trusted, operational partnership rooted in reliability and technical consistency. AMBRY GENETICS primarily operates under NAICS 621511, which encompasses medical laboratories offering clinical diagnostic services, particularly in molecular genetics. Their market positioning centers on reference laboratory services for government-funded healthcare systems, emphasizing high-throughput, low-turnaround genetic testing that supports clinical decision-making. They serve as a critical extension of provider networks requiring specialized genomic capabilities not available in routine clinical labs. As a privately held entity headquartered in Aliso Viejo, California, AMBRY GENETICS CORPORATION operates as a 2L structure with no active government certifications on record. The company’s geographic presence is centralized in Southern California, with its laboratory and bioinformatics operations supporting federal healthcare contracts nationwide. Their market positioning reflects a niche focus on genetic diagnostics within the federal medical services ecosystem.